Free Trial
NASDAQ:YTEN

Yield10 Bioscience (YTEN) Stock Price, News & Analysis

Yield10 Bioscience logo
$0.02 0.00 (0.00%)
As of 02/20/2025

About Yield10 Bioscience Stock (NASDAQ:YTEN)

Key Stats

Today's Range
$0.0150
$0.0150
50-Day Range
$0.00
$0.40
52-Week Range
$0.31
$17.26
Volume
N/A
Average Volume
78,164 shs
Market Capitalization
$11,010.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

Receive YTEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.

YTEN Stock News Headlines

$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
See More Headlines

YTEN Stock Analysis - Frequently Asked Questions

Yield10 Bioscience's stock was trading at $0.3120 at the start of the year. Since then, YTEN shares have decreased by 95.2% and is now trading at $0.0150.
View the best growth stocks for 2025 here
.

Yield10 Bioscience, Inc. (NASDAQ:YTEN) posted its quarterly earnings results on Tuesday, November, 9th. The specialty chemicals company reported ($11.76) earnings per share for the quarter, topping analysts' consensus estimates of ($15.60) by $3.84. The specialty chemicals company had revenue of $0.09 million for the quarter, compared to analysts' expectations of $0.22 million.

Yield10 Bioscience's stock reverse split on Friday, May 3rd 2024. The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Yield10 Bioscience investors own include Canopy Growth (CGC), KushCo (KSHB), NVIDIA (NVDA), Advanced Micro Devices (AMD), OPKO Health (OPK), Pfizer (PFE) and FuelCell Energy (FCEL).

Company Calendar

Last Earnings
11/09/2021
Today
2/22/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Agricultural production - crops
Sub-Industry
Agriculture
Current Symbol
NASDAQ:YTEN
Employees
30
Year Founded
1992

Profitability

Net Income
$-14,450,000.00
Pretax Margin
-1,693.60%

Debt

Sales & Book Value

Annual Sales
$60,000.00
Book Value
($4.97) per share

Miscellaneous

Free Float
689,000
Market Cap
$11,010.00
Optionable
Not Optionable
Beta
1.48

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:YTEN) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners